Real-life practice of reflectance confocal microscopy in France: A prospective multicenter study.

Basal cell carcinoma Confocal microscopy Dermatopathology Lentigo/Lentigo maligna Melanoma Public Health

Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
20 Feb 2024
Historique:
received: 27 07 2023
revised: 03 12 2023
accepted: 10 01 2024
medline: 23 2 2024
pubmed: 23 2 2024
entrez: 22 2 2024
Statut: aheadofprint

Résumé

Studies demonstrating the potential utility of reflectance confocal microscopy (RCM) have been performed under experimental conditions. To provide an overview of RCM practice in real-life. A multicenter, prospective study carried out in 10 university dermatology departments in France. 0verall, 410 patients were enrolled. Half of the patients (48%) were referred by private-practice dermatologists. They were referred for diagnosis (84.9%) or pre-surgical mapping (13%). For diagnosis, the lesions were located on the face (62%), arms and legs (14.9%), and trunk (13,6%), and pre-surgical mapping was almost exclusively on the face (90.9%). Among those referred for diagnosis, the main indication was suspicion of a skin tumor (92.8%). Of these,50.6% were spared biopsies after RCM. When RCM indicated surgery, histology revealed malignant lesions in 72.7% of cases. The correlation between RCM and histopathology was high, with a correlation rate of 82.76% and a kappa coefficient of 0.73 (0.63; 0.82). This study was performed in the settings of French tertiary referral hospitals. This study shows that in real-life RCM can be integrated into the workflow of a public private network, which enables a less invasive diagnostic procedure for patients.

Sections du résumé

BACKGROUND BACKGROUND
Studies demonstrating the potential utility of reflectance confocal microscopy (RCM) have been performed under experimental conditions.
OBJECTIVE OBJECTIVE
To provide an overview of RCM practice in real-life.
METHODS METHODS
A multicenter, prospective study carried out in 10 university dermatology departments in France.
RESULTS RESULTS
0verall, 410 patients were enrolled. Half of the patients (48%) were referred by private-practice dermatologists. They were referred for diagnosis (84.9%) or pre-surgical mapping (13%). For diagnosis, the lesions were located on the face (62%), arms and legs (14.9%), and trunk (13,6%), and pre-surgical mapping was almost exclusively on the face (90.9%). Among those referred for diagnosis, the main indication was suspicion of a skin tumor (92.8%). Of these,50.6% were spared biopsies after RCM. When RCM indicated surgery, histology revealed malignant lesions in 72.7% of cases. The correlation between RCM and histopathology was high, with a correlation rate of 82.76% and a kappa coefficient of 0.73 (0.63; 0.82).
LIMITATIONS CONCLUSIONS
This study was performed in the settings of French tertiary referral hospitals.
CONCLUSION CONCLUSIONS
This study shows that in real-life RCM can be integrated into the workflow of a public private network, which enables a less invasive diagnostic procedure for patients.

Identifiants

pubmed: 38387851
pii: S0190-9622(24)00383-9
doi: 10.1016/j.jaad.2024.01.079
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

M Stefanski (M)

Department of Oncodermatology, Reims University Hospital, Reims France; Department of Dermatology, Saint Vincent de Paul Hospital, Hospital Group of the Catholic Institute of Lille, Lille France.

A Le Guern (A)

Department of Dermatology, Saint Vincent de Paul Hospital, Hospital Group of the Catholic Institute of Lille, Lille France.

L Visseaux (L)

Department of Medical Oncology, Institut Godinot, Reims France.

M Ehret (M)

Department of Dermatology, Emile Muller Hospital, Mulhouse France.

M Colomb (M)

Department of Oncodermatology, Reims University Hospital, Reims France.

G Jeudy (G)

Department of Dermatology, Dijon University Hospital, Dijon France.

F Le Duff (F)

Department of Dermatology, Nice University Hospital, Nice France.

M Vourc'h (M)

Department of Dermatology, Nantes University Hospital, Nantes France.

B Baroudjian (B)

Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris, France.

R Perea-Villacorta (R)

Department of Dermatology, Clermont-Ferrand University Hospital, Clermont-Ferrand France.

C Bernigaud (C)

Department of Dermatology, AP-HP, Henri Mondor Hospital, Paris France.

S Mallet (S)

Department of Dermatology and skin cancers, La Timone Hospital, AP-HM, Aix-Marseille University, Marseille France.

L Norberciak (L)

Delegation of Clinical Research and Innovation, Biostatistics, Saint Philibert Hospital, Catholic University of Lille, Lille France.

S Debarbieux (S)

Department of Dermatology, Lyon University Hospital, Lyon France.

J-L Perrot (JL)

Department of Dermatology, Saint Etienne University Hospital et Laboratoire Hubert Curien UMR CNRS 5516, Saint Etienne France.

F Grange (F)

Department of Dermatology, Valence Hospital, Valence France.

P Modiano (P)

Department of Dermatology, Saint Vincent de Paul Hospital, Hospital Group of the Catholic Institute of Lille, Lille France.

J Monnier (J)

Department of Dermatology and skin cancers, La Timone Hospital, AP-HM, Aix-Marseille University, Marseille France.

P Bahadoran (P)

Department of Dermatology, Nice University Hospital, Nice France. Electronic address: bahadoran.p@chu-nice.fr.

Classifications MeSH